Evelo Biosciences announced the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,576,111, entitled “Method of treating cancer using Bifidobacterium animalis ssp.
Evelo Biosciences announced a collaboration with Mayo Clinic to develop and commercialize monoclonal microbials for the treatment of inflammatory and neuroinflammatory diseases.